Biomarkers in Clinical Trials Archives - Page 4 of 8

Biomarkers triple clinical trial success rate, says report

May 26, 2016 | Biomarkers, News

Biomarkers triple clinical trial success rate, says report By Melissa Fassbender, 26-May-2016 A recent study of clinical drug development success rates found that biomarker-enabled drug programs are three times more likely to reach approval....

Cancer Drugs Are The Least Likely to Receive FDA Approval

May 26, 2016 | News

This article was originally published on Fortune.com, by Sy Mukherjee May 26, 2016. But there’s good reason to hope that may change very soon. This post was corrected/updated on Monday, May 30. A massive new study of drug candidates sheds light on which experimental...

Amplion, BIO, and BioMedTracker release new report on ground breaking role biomarkers have in increasing Likelihood of Approval (LOA)

May 25, 2016 | Biomarkers, News

New Report from Amplion, BIO, and BioMedTracker examined ~10,000 clinical trials to make groundbreaking conclusion regarding biomarkers. Bend, Ore., May 25, 2016., May 25, 2016 – Amplion (developers of BiomarkerBaseTM), Biomedtracker, and BIO announces the...

Biomarkers Triple Clinical Trial Success Rate According To Largest Study Of Its Kind

May 25, 2016 | Biomarkers, News

New Report from Amplion, BIO, and BioMedTracker examined ~10,000 clinical trials to make groundbreaking conclusion regarding biomarkers. 09:25 ET from Amplion BEND, Ore., May 25, 2016 /PRNewswire/ — Amplion (inventors of BiomarkerBase™), Biomedtracker,...

Report suggests drug-approval rate now just 1-in-10

May 25, 2016 | News

This article was originally published on Boston Business Journal on May 25, 2016 by Don Seiffert A report released today by the biotech industry’s national trade group finds less than one of every 10 drugs that enter clinical trials is ultimately approved by the Food...

« Older Entries

Next Entries »